The Kalamazoo, Michigan-based orthopedic device maker posted a net profit of $276.1 million, or 66 cents per share, compared with a profit of $227.9 million, or 55 cents per share, a year earlier.
NEW YORK (Reuters) - Stryker Corp <SYK.N>, which this week said it was recalling some of its artificial hip products, on Wednesday reported higher fourth-quarter profit on increased sales of its orthopedic implants and surgical equipment.
The Kalamazoo, Michigan-based orthopedic device maker posted a net profit of $276.1 million, or 66 cents per share, compared with a profit of $227.9 million, or 55 cents per share, a year earlier.
Analysts on average had expected 66 cents per share, according to Reuters Estimates.
(Reporting by Bill Berkrot, editing by Richard Chang)
!ADVERTISEMENT!
